Yulia Slavina

REGENXBIO hosts MPS advocacy leaders to strengthen patient partnerships

REGENXBIO hosts MPS advocacy leaders to strengthen patient partnerships
REGENXBIO hosts MPS advocates

REGENXBIO welcomed key MPS advocacy leaders including Kim Stephens, Mark Dant, Sharon King, and Scott Loiler this week.

During the visit, these advocates shared firsthand experiences, discussed ongoing unmet needs in the mucopolysaccharidosis (MPS) community, and highlighted the importance of strategic partnerships. REGENXBIO expressed appreciation for the advocates' commitment to supporting patients and families, underscoring the crucial role of collaboration in advancing care and resources for those impacted by rare diseases.

REGENXBIO has previously reported promising pivotal data for its RGX-202 Duchenne muscular dystrophy program at a national conference, according to earlier disclosures. The company has also participated in global MPS events in Florence, supporting international collaboration on lysosomal disease solutions as noted here. These efforts reflect ongoing engagement with both research and advocacy communities.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.